Next Article in Journal
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry
Next Article in Special Issue
Updated Prognostic Factors in Localized NSCLC
Previous Article in Journal
Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines
Previous Article in Special Issue
First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes
 
 
Article

Article Versions Notes

Cancers 2021, 13(23), 6139; https://doi.org/10.3390/cancers13236139
Action Date Notes Link
article xml file uploaded 6 December 2021 12:20 CET Original file -
article xml uploaded. 6 December 2021 12:20 CET Update https://www.mdpi.com/2072-6694/13/23/6139/xml
article pdf uploaded. 6 December 2021 12:20 CET Version of Record https://www.mdpi.com/2072-6694/13/23/6139/pdf
article supplementary file uploaded. 6 December 2021 12:20 CET - https://www.mdpi.com/2072-6694/13/23/6139#supplementary
article html file updated 6 December 2021 12:22 CET Original file -
article html file updated 30 July 2022 20:43 CEST Update https://www.mdpi.com/2072-6694/13/23/6139/html
Back to TopTop